Transthyretin Stabilizer Market, Global Outlook and Forecast 2023-2029

Report ID: MMG63235 | Category: Pharma & Healthcare | Pages: 79 | Format: PDF | Published Date: March 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.
This report aims to provide a comprehensive presentation of the global market for Transthyretin Stabilizer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transthyretin Stabilizer. This report contains market size and forecasts of Transthyretin Stabilizer in global, including the following market information:
Global Transthyretin Stabilizer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Transthyretin Stabilizer Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Transthyretin Stabilizer companies in 2022 (%)
The global Transthyretin Stabilizer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Diflunisal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Transthyretin Stabilizer include Pfizer Inc., Merck & Co., AstraZeneca Plc., GlaxoSmithKline Plc., Corino Therapeutics Inc., Alnylam Pharmaceuticals, Bellus Health Inc., Ionis Pharmaceuticals, Inc. and Proclara Bioscience, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transthyretin Stabilizer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transthyretin Stabilizer Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transthyretin Stabilizer Market Segment Percentages, by Type, 2022 (%)
Diflunisal
Tafamidis
Others
Global Transthyretin Stabilizer Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transthyretin Stabilizer Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Global Transthyretin Stabilizer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Transthyretin Stabilizer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transthyretin Stabilizer revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Transthyretin Stabilizer revenues share in global market, 2022 (%)
Key companies Transthyretin Stabilizer sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Transthyretin Stabilizer sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Merck & Co.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Corino Therapeutics Inc.
Alnylam Pharmaceuticals
Bellus Health Inc.
Ionis Pharmaceuticals, Inc.
Proclara Bioscience
Arturus Therapeutics
Prothena Corporation Plc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transthyretin Stabilizer, market overview.
Chapter 2: Global Transthyretin Stabilizer market size in revenue and volume.
Chapter 3: Detailed analysis of Transthyretin Stabilizer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transthyretin Stabilizer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transthyretin Stabilizer capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Transthyretin Stabilizer Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Transthyretin Stabilizer Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Transthyretin Stabilizer Overall Market Size
    2.1 Global Transthyretin Stabilizer Market Size: 2022 VS 2029
    2.2 Global Transthyretin Stabilizer Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Transthyretin Stabilizer Sales: 2018-2029
3 Company Landscape
    3.1 Top Transthyretin Stabilizer Players in Global Market
    3.2 Top Global Transthyretin Stabilizer Companies Ranked by Revenue
    3.3 Global Transthyretin Stabilizer Revenue by Companies
    3.4 Global Transthyretin Stabilizer Sales by Companies
    3.5 Global Transthyretin Stabilizer Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Transthyretin Stabilizer Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Transthyretin Stabilizer Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Transthyretin Stabilizer Players in Global Market
        3.8.1 List of Global Tier 1 Transthyretin Stabilizer Companies
        3.8.2 List of Global Tier 2 and Tier 3 Transthyretin Stabilizer Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Transthyretin Stabilizer Market Size Markets, 2022 & 2029
        4.1.2 Diflunisal
        4.1.3 Tafamidis
        4.1.4 Others
    4.2 By Type - Global Transthyretin Stabilizer Revenue & Forecasts
        4.2.1 By Type - Global Transthyretin Stabilizer Revenue, 2018-2023
        4.2.2 By Type - Global Transthyretin Stabilizer Revenue, 2024-2029
        4.2.3 By Type - Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
    4.3 By Type - Global Transthyretin Stabilizer Sales & Forecasts
        4.3.1 By Type - Global Transthyretin Stabilizer Sales, 2018-2023
        4.3.2 By Type - Global Transthyretin Stabilizer Sales, 2024-2029
        4.3.3 By Type - Global Transthyretin Stabilizer Sales Market Share, 2018-2029
    4.4 By Type - Global Transthyretin Stabilizer Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Transthyretin Stabilizer Market Size, 2022 & 2029
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Drug Stores
        5.1.5 Online Pharmacies
        5.1.6 Others
    5.2 By Application - Global Transthyretin Stabilizer Revenue & Forecasts
        5.2.1 By Application - Global Transthyretin Stabilizer Revenue, 2018-2023
        5.2.2 By Application - Global Transthyretin Stabilizer Revenue, 2024-2029
        5.2.3 By Application - Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
    5.3 By Application - Global Transthyretin Stabilizer Sales & Forecasts
        5.3.1 By Application - Global Transthyretin Stabilizer Sales, 2018-2023
        5.3.2 By Application - Global Transthyretin Stabilizer Sales, 2024-2029
        5.3.3 By Application - Global Transthyretin Stabilizer Sales Market Share, 2018-2029
    5.4 By Application - Global Transthyretin Stabilizer Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Transthyretin Stabilizer Market Size, 2022 & 2029
    6.2 By Region - Global Transthyretin Stabilizer Revenue & Forecasts
        6.2.1 By Region - Global Transthyretin Stabilizer Revenue, 2018-2023
        6.2.2 By Region - Global Transthyretin Stabilizer Revenue, 2024-2029
        6.2.3 By Region - Global Transthyretin Stabilizer Revenue Market Share, 2018-2029
    6.3 By Region - Global Transthyretin Stabilizer Sales & Forecasts
        6.3.1 By Region - Global Transthyretin Stabilizer Sales, 2018-2023
        6.3.2 By Region - Global Transthyretin Stabilizer Sales, 2024-2029
        6.3.3 By Region - Global Transthyretin Stabilizer Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Transthyretin Stabilizer Revenue, 2018-2029
        6.4.2 By Country - North America Transthyretin Stabilizer Sales, 2018-2029
        6.4.3 US Transthyretin Stabilizer Market Size, 2018-2029
        6.4.4 Canada Transthyretin Stabilizer Market Size, 2018-2029
        6.4.5 Mexico Transthyretin Stabilizer Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Transthyretin Stabilizer Revenue, 2018-2029
        6.5.2 By Country - Europe Transthyretin Stabilizer Sales, 2018-2029
        6.5.3 Germany Transthyretin Stabilizer Market Size, 2018-2029
        6.5.4 France Transthyretin Stabilizer Market Size, 2018-2029
        6.5.5 U.K. Transthyretin Stabilizer Market Size, 2018-2029
        6.5.6 Italy Transthyretin Stabilizer Market Size, 2018-2029
        6.5.7 Russia Transthyretin Stabilizer Market Size, 2018-2029
        6.5.8 Nordic Countries Transthyretin Stabilizer Market Size, 2018-2029
        6.5.9 Benelux Transthyretin Stabilizer Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Transthyretin Stabilizer Revenue, 2018-2029
        6.6.2 By Region - Asia Transthyretin Stabilizer Sales, 2018-2029
        6.6.3 China Transthyretin Stabilizer Market Size, 2018-2029
        6.6.4 Japan Transthyretin Stabilizer Market Size, 2018-2029
        6.6.5 South Korea Transthyretin Stabilizer Market Size, 2018-2029
        6.6.6 Southeast Asia Transthyretin Stabilizer Market Size, 2018-2029
        6.6.7 India Transthyretin Stabilizer Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Transthyretin Stabilizer Revenue, 2018-2029
        6.7.2 By Country - South America Transthyretin Stabilizer Sales, 2018-2029
        6.7.3 Brazil Transthyretin Stabilizer Market Size, 2018-2029
        6.7.4 Argentina Transthyretin Stabilizer Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Transthyretin Stabilizer Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Transthyretin Stabilizer Sales, 2018-2029
        6.8.3 Turkey Transthyretin Stabilizer Market Size, 2018-2029
        6.8.4 Israel Transthyretin Stabilizer Market Size, 2018-2029
        6.8.5 Saudi Arabia Transthyretin Stabilizer Market Size, 2018-2029
        6.8.6 UAE Transthyretin Stabilizer Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Pfizer Inc.
        7.1.1 Pfizer Inc. Company Summary
        7.1.2 Pfizer Inc. Business Overview
        7.1.3 Pfizer Inc. Transthyretin Stabilizer Major Product Offerings
        7.1.4 Pfizer Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.1.5 Pfizer Inc. Key News & Latest Developments
    7.2 Merck & Co.
        7.2.1 Merck & Co. Company Summary
        7.2.2 Merck & Co. Business Overview
        7.2.3 Merck & Co. Transthyretin Stabilizer Major Product Offerings
        7.2.4 Merck & Co. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.2.5 Merck & Co. Key News & Latest Developments
    7.3 AstraZeneca Plc.
        7.3.1 AstraZeneca Plc. Company Summary
        7.3.2 AstraZeneca Plc. Business Overview
        7.3.3 AstraZeneca Plc. Transthyretin Stabilizer Major Product Offerings
        7.3.4 AstraZeneca Plc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.3.5 AstraZeneca Plc. Key News & Latest Developments
    7.4 GlaxoSmithKline Plc.
        7.4.1 GlaxoSmithKline Plc. Company Summary
        7.4.2 GlaxoSmithKline Plc. Business Overview
        7.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Major Product Offerings
        7.4.4 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.4.5 GlaxoSmithKline Plc. Key News & Latest Developments
    7.5 Corino Therapeutics Inc.
        7.5.1 Corino Therapeutics Inc. Company Summary
        7.5.2 Corino Therapeutics Inc. Business Overview
        7.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Major Product Offerings
        7.5.4 Corino Therapeutics Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.5.5 Corino Therapeutics Inc. Key News & Latest Developments
    7.6 Alnylam Pharmaceuticals
        7.6.1 Alnylam Pharmaceuticals Company Summary
        7.6.2 Alnylam Pharmaceuticals Business Overview
        7.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Major Product Offerings
        7.6.4 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.6.5 Alnylam Pharmaceuticals Key News & Latest Developments
    7.7 Bellus Health Inc.
        7.7.1 Bellus Health Inc. Company Summary
        7.7.2 Bellus Health Inc. Business Overview
        7.7.3 Bellus Health Inc. Transthyretin Stabilizer Major Product Offerings
        7.7.4 Bellus Health Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.7.5 Bellus Health Inc. Key News & Latest Developments
    7.8 Ionis Pharmaceuticals, Inc.
        7.8.1 Ionis Pharmaceuticals, Inc. Company Summary
        7.8.2 Ionis Pharmaceuticals, Inc. Business Overview
        7.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Major Product Offerings
        7.8.4 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.8.5 Ionis Pharmaceuticals, Inc. Key News & Latest Developments
    7.9 Proclara Bioscience
        7.9.1 Proclara Bioscience Company Summary
        7.9.2 Proclara Bioscience Business Overview
        7.9.3 Proclara Bioscience Transthyretin Stabilizer Major Product Offerings
        7.9.4 Proclara Bioscience Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.9.5 Proclara Bioscience Key News & Latest Developments
    7.10 Arturus Therapeutics
        7.10.1 Arturus Therapeutics Company Summary
        7.10.2 Arturus Therapeutics Business Overview
        7.10.3 Arturus Therapeutics Transthyretin Stabilizer Major Product Offerings
        7.10.4 Arturus Therapeutics Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.10.5 Arturus Therapeutics Key News & Latest Developments
    7.11 Prothena Corporation Plc.
        7.11.1 Prothena Corporation Plc. Company Summary
        7.11.2 Prothena Corporation Plc. Transthyretin Stabilizer Business Overview
        7.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Major Product Offerings
        7.11.4 Prothena Corporation Plc. Transthyretin Stabilizer Sales and Revenue in Global (2018-2023)
        7.11.5 Prothena Corporation Plc. Key News & Latest Developments
8 Global Transthyretin Stabilizer Production Capacity, Analysis
    8.1 Global Transthyretin Stabilizer Production Capacity, 2018-2029
    8.2 Transthyretin Stabilizer Production Capacity of Key Manufacturers in Global Market
    8.3 Global Transthyretin Stabilizer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Transthyretin Stabilizer Supply Chain Analysis
    10.1 Transthyretin Stabilizer Industry Value Chain
    10.2 Transthyretin Stabilizer Upstream Market
    10.3 Transthyretin Stabilizer Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Transthyretin Stabilizer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Transthyretin Stabilizer Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?